Notice
17 Apr 2025
nih, biomedical, technology transfer, patent licensing, electroporation, cambridge enterprise, health innovation
🧬Exclusive Patent License Opportunity for Biomedical Innovations
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Cambridge Enterprise Limited, University of Cambridge, located in Cambridge, United Kingdom, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.
Learn More